Bionano Genomics Inc. (BNGO) said Friday it has priced an underwritten public offering of 29 million shares at $3.05 a share. The stock closed Thursday at $5.00. The genome analysis company has granted the underwriters -- Oppenheimer & Co., which is sole bookrunner, while BTIG acted as lead manager and Ladenburg Thalman and Maxim Group acted as co-managers -- a 30-day option to acquire an additional 4.3 million shares at the offering price. The stock, which has been volatile in recent sessions, slid 18% premarket, but is up more than 300% in the last 12 months, while the SPDR S&P Biotech ETF (XBI) has gained 58% and the S&P 500 has gained 17.5%.
-Ciara Linnane; 415-439-6400; AskNewswires@dowjones.com
(END) Dow Jones Newswires
January 08, 2021 09:16 ET (14:16 GMT)
Copyright (c) 2021 Dow Jones & Company, Inc.